[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602118":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":29,"responsibleParty":49,"collaborators":11,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":11,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"EOI block group","EXPERIMENTAL",null,[13],"Procedure: EOI block",{"label":15,"type":16,"description":11,"interventionNames":17},"control group","SHAM_COMPARATOR",[18],"Procedure: sham block",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"PROCEDURE","EOI block","EOI block with 0.25% ropivacaine 1 mL\u002Fkg (max 40 mL) bilaterally under ultrasound guidance",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"sham block","Sham block with equal volume of normal saline bilaterally under ultrasound guidance",[15],[30],{"facility":31,"status":32,"city":33,"state":11,"zip":34,"country":35,"countryCode":11,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Seoul National University Children's Hospital","RECRUITING","Seoul","110-744","South Korea",{"type":37,"coordinates":38},"Point",[39,40],126.9784,37.566,{"lat":40,"lon":39},[43],{"name":44,"role":45,"phone":46,"phoneExt":47,"email":48},"Jin-Tae Kim, M.D.,Ph.D.","CONTACT","0220723664","82","jb4001@snu.ac.kr",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Jin-Tae Kim","professor","100602118","eoi-block-for-laparoscopic-gastrostomy-100602118",false,"NCT07119346","EOI Block for Laparoscopic Gastrostomy","Effect of Ultrasound-guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Laparoscopic Gastrostomy: A Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital\n\nAge ≥3 and \\\u003C18 years\n\nExclusion Criteria:\n\n* Unstable vital signs\n\nContraindications to ropivacaine or opioids\n\nSevere hepatic or renal dysfunction\n\nOther investigator-determined ineligibility","ALL","3 Years","17 Years",{"count":64,"type":65},40,"ESTIMATED","INTERVENTIONAL",[68],"NA","This randomized controlled trial will evaluate the efficacy of ultrasound-guided external oblique intercostal fascial plane (EOI) block in reducing intraoperative and postoperative pain in pediatric patients undergoing laparoscopic gastrostomy under general anesthesia. Forty patients aged 3-18 years will be randomly allocated to receive either bilateral EOI block with 0.25% ropivacaine or sham block with normal saline. Primary outcome is percent change in heart rate at surgical incision. Secondary outcomes include intraoperative fentanyl use, perioperative analgesic requirements, postoperative pain scores (r-Face, Legs, Activity, Cry, Consolability(r-FLACC) and Pediatric Pain Profile), Analgesia Nociception Index values, and analgesia-related adverse events.",[71],"Gastrostomy","2025-08-11",{"date":74,"type":75},"2025-08-13","ACTUAL",{"date":77,"type":65},"2025-08",{"date":79,"type":65},"2028-05",{"name":5,"class":6},1]